Boehringer Ingelheim International GmbH
- Address
- Binger Strasse 173
Sponsor Overview
Specializations
Oncology and Targeted Cancer Therapy
Clinical research spans non-small cell lung cancer, small cell lung cancer, neuroendocrine neoplasms, HER2-mutated solid tumours, pancreatic ductal adenocarcinoma, biliary tract cancer, urothelial bladder cancer, gastric and gastroesophageal junction adenocarcinoma, colorectal cancer, breast cancer, melanoma, and dedifferentiated liposarcoma.
- HER2-driven malignancies
- DLL3-expressing neuroendocrine cancers
- Advanced solid tumours
- Metastatic and unresectable cancer
Research also includes tumour-directed approaches across gastrointestinal, thoracic, and genitourinary oncology, with attention to objective response, progression-free survival, and disease control.
Pulmonary and Fibrotic Lung Disease
The sponsor funds studies in idiopathic pulmonary fibrosis, progressive pulmonary fibrosis, progressive fibrosing interstitial lung diseases, systemic sclerosis-associated interstitial lung disease, childhood interstitial lung disease, bronchiectasis, cystic fibrosis bronchiectasis, and cystic fibrosis.
- Interstitial lung diseases
- Pulmonary fibrosis
- Chronic cough
- Airway inflammation and lung function
Additional work covers respiratory symptom burden and long-term management of fibrosing lung disorders, with outcomes tied to forced vital capacity and exacerbations.
Cardiometabolic, Renal, and Hepatic Disease
Research activity includes heart failure, acute myocardial infarction, cardiovascular disease, hypertension, type 2 diabetes, obesity, overweight, chronic kidney disease, proteinuric kidney disease, renal impairment, liver cirrhosis, portal hypertension, and metabolic dysfunction-associated steatohepatitis.
- Cardiorenal syndromes
- Congestive heart failure
- Advanced fibrosis and cirrhosis
- Metabolic liver disease
Trials also address haemodynamic liver complications, kidney function decline, and cardiometabolic risk in populations with overlapping diabetes and vascular disease.
Dermatology, Autoimmune Disease, and Rare Inflammatory Disorders
Clinical studies extend to hidradenitis suppurativa, generalized pustular psoriasis, plaque psoriasis, pyoderma gangrenosum, Netherton syndrome, systemic lupus erythematosus, systemic sclerosis, type 1 interferonopathies, and systemic autoimmune rheumatic diseases.
- Immune-mediated skin disease
- Autoinflammatory disorders
- Connective tissue disease
- Recurrent flare management
Work in this area includes chronic inflammatory dermatoses and rare immune conditions where symptom burden, flare control, and longer-term disease activity are central concerns.
Ophthalmology, Neurology, and Psychiatry
The portfolio also covers diabetic retinopathy, centre-involved diabetic macular edema, acute ischemic stroke, attention deficit hyperactivity disorder, schizophrenia, major depressive disorder, and borderline personality disorder.
- Retinal vascular disease
- Neuropsychiatric disorders
- Stroke and cerebrovascular disease
- Cognitive impairment in schizophrenia
These studies include vision-threatening diabetic eye disease and central nervous system disorders with emphasis on functional outcomes, symptom relief, and disease progression.
Sponsored Trials
Data & Insights
This sponsor works with 51 molecules, of which 5 are not being studied by other sponsors.
This sponsor has worked with 1304 sites across their trial portfolio.
Therapeutic Focus
- 1.Not possible to specify67 trials220 other sponsors
- 2.Neoplasms41 trials853 other sponsors
- 3.Respiratory Tract Diseases16 trials277 other sponsors
- 4.Nutritional and Metabolic Diseases13 trials211 other sponsors
- 5.Cardiovascular Diseases8 trials359 other sponsors
- 6.Skin and Connective Tissue Diseases6 trials247 other sponsors
- 7.Eye Diseases5 trials138 other sponsors
- 8.Mental Disorders3 trials150 other sponsors
- 9.Digestive System Diseases2 trials280 other sponsors
- 10.Female Urogenital Diseases and Pregnancy Complications2 trials142 other sponsors
- 11.Immune System Diseases2 trials322 other sponsors
- 12.Male Urogenital Diseases2 trials111 other sponsors
- 13.Bacterial Infections and Mycoses1 trial180 other sponsors
- 14.Behavior and Behavior Mechanisms1 trial38 other sponsors
- 15.Congenital, Hereditary, and Neonatal Diseases and Abnormalities1 trial165 other sponsors
- 16.Metabolism1 trial38 other sponsors
- 17.Nervous System Diseases1 trial449 other sponsors
- 18.Physiological processes1 trial28 other sponsors
- 19.Reproductive and Urinary Physiological Phenomena1 trial33 other sponsors
Partnered Research Centres
1304 centres- Address
- Juglas street 20, LV-1079 Riga
- Address
- ul. Partyzantow 39/64, 81-423 Gdynia
- Address
- Ul. Rudolfa Weigla 5, 53-114 Wroclaw
- Address
- Sumavska 2, Vychodni Predmesti, 301 00 Pilsen
- Address
- Via Consolare Valeria N 1, 98124 Messina
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Boehringer Ingelheim International GmbH.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.